Judges Scientific (JDG) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
22 Jan, 2026Trading conditions
Market challenges, especially US federal funding uncertainty, led to underperformance against expectations for 2025.
Satisfactory results in Europe and China were offset by continued weakness in the USA.
Reduced investments in offshore wind impacted H2 growth.
Order intake
Organic order intake weakened through 2025, ending the year down 6% year-on-year.
US orders declined 23%, with additional weakness from offshore wind markets.
2025 financial performance
Adjusted earnings per share for 2025 expected to be around 275p, 6% below market expectations.
Cash conversion remains strong and in line with historical performance.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Judges Scientific
- H1 profits fell, but acquisitions, dividend growth, and H2 outlook improved.JDG
H1 202420 Jan 2026 - 2024 saw lower revenue and profit but strong cash flow, acquisitions, and dividend growth.JDG
H2 20241 Dec 2025 - Strong revenue and profit growth, but US market headwinds and funding cuts persist.JDG
H1 202518 Sep 2025 - FY25 EPS guidance cut due to US headwinds, but order book and cash remain strong.JDG
Trading Update24 Jul 2025 - 2024 earnings guidance lowered as delayed orders impact full-year results despite H2 progress.JDG
Trading Update13 Jun 2025 - Earnings per share for 2024 are now forecast 5–10% below consensus after a subdued H1.JDG
Trading Update13 Jun 2025 - 2024 was challenging for Judges Scientific, but 2025 starts with improved outlook and cash conversion.JDG
Trading Update6 Jun 2025